ClearPoint Neuro secures up to $110M from Oberland Capital with $33.5M funded at closing

ClearPoint Neuro, Inc.

Enters note agreement for up to $105M; $30M funded at closing, up to $25M optional second tranche, up to $50M third tranche.
Issues 275,808 shares at $12.69 in registered direct offering for $3.5M gross proceeds.
Notes bear interest at Term SOFR + 3.95% (min 8.25%, cap 9.50%); first six quarters 50% PIK interest.
Proceeds for general corporate purposes; no financial covenants; secured by substantially all assets including IP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.